Navigation Links
Cervical Cancer Can Now Be Better Handled With Gene Silencing Therapy

Queensland University researchers have ventured into a new approach called ‘gene silencing’ for the treatment of cervical cancer. The technique is targeted towards turning // the cancer causing genes on and off to help cervical cancer patients.

Certain genes called tumor suppressor genes are responsible for preventing the occurrence of a particular type of cancer. On the other hand, tumor-promoting genes help in the initiation and progression of tumor. A logical way to combat tumor is to either turn on the tumor suppressor genes or turn off the tumor promoting genes.

Cervical cancer is the leading cause of cancer death in women aged 25-50 worldwide. Infection with the human papilloma virus is regarded to be a causative factor in cervical cancer as it results in the over-production of two viral cancer-causing genes called E6 and E7.

The researchers were successful in killing the cervical cancer cells by turning of the production of these genes in cancer cells. Furthermore, gene silencing was found to enhance the effect of chemotherapy by up to four times.

One main advantage of this approach is that the normal cells remain unaffected during manipulation, as the main target is the viral gene. The researchers hope to exploit this form of treatment to all forms of cervical cancer including the premalignant lesions picked up by the pap smear and especially for advanced cervical cancers where the cancer has moved to other sites such as the lung or liver.

The current results have been demonstrated in cervical cancer cell lines grown in test tubes. The next step is to achieve the same desired effect in animal models. If successful, the next stage of research will focus on the development of materials for human trials to allow proper delivery of the drug to patients and to investigate whether other cancer types can be treated this way.

Although the trials are under an experimental phase, if successful, it
'"/>




Page: 1 2

Related medicine news :

1. Virus Level could Predict Cervical Cancer Risk
2. Smallpox Vaccine May Help Fight Cervical Cancer
3. Obesity Increases Risk of Cervical Cancer
4. Reducing The Risk Of Cervical Cancer
5. Improving Fertility In Patients With Cervical Cancer
6. Vaccine for Cervical cancer
7. Cervical spinal injury patients may have more damage left undetected
8. Cervical Cancer Vaccine To Be Developed In India
9. Cervical Cancer Recurrence Risk Even After Removal Of Pre-Cancerous Cells
10. HPV Vaccines for Cervical Cancer
11. Vaccine For Cervical Cancer Awaits Approval
Post Your Comments:
(Date:8/28/2008)...67%, but patients and doctors say drug is hard to ...News) -- Only 40 percent of patients with atrial f...id suffer a stroke were taking the anti-clotting d...taking warfarin, 75 percent weren,t getting the do...5 percent were taking medications that were less e...
(Date:8/28/2008).../PRNewswire-FirstCall/ -- Versus,Technology, Inc. ...$1,176,000 for its third fiscal quarter ended July...f $1,283,000 for the same quarter of the prior,yea...8, were $4,026,000,compared to $3,554,000 for the...Versus, quarterly revenues can vary significantly ...
(Date:8/28/2008)...jury itself, associated with increased plaque , ...group of researchers has described hourly changes ...a key role in Alzheimer,s disease. , In a 2005...rectly linked to brain cell communication in a mou...ommunication increased, so did amyloid beta. When ...
(Date:8/28/2008)...www.parkercenter.net/ [New Jersey plastic surgeon...inoplasty, an advanced type of tummy tuck, for the...lpted tummies and their quick recovery from surger...d two significant refinements to the procedure mak... Paramus, NJ (PRWEB) August 28, ...
Breaking Medicine News(10 mins):Health News:Most Patients With Irregular Heartbeat Take Inadequate Blood Thinner Dose 2Health News:Most Patients With Irregular Heartbeat Take Inadequate Blood Thinner Dose 3Health News:Versus Technology Announces Third Quarter Results 2Health News:Versus Technology Announces Third Quarter Results 3Health News:Versus Technology Announces Third Quarter Results 4Health News:Versus Technology Announces Third Quarter Results 5Health News:Versus Technology Announces Third Quarter Results 6Health News:Scientists Track Hourly Changes in Alzheimer's Protein 2Health News:Lipoabdominoplasty: A New Type of Tummy Tuck Gets Even Better 2Health News:Lipoabdominoplasty: A New Type of Tummy Tuck Gets Even Better 3Health News:Lipoabdominoplasty: A New Type of Tummy Tuck Gets Even Better 4
...ted by the type 3 virus which spreads by bugs and ...t most of the winegrowers have bought the national...free from the virus. New Zealand Winegrowers scien...said that a lot of research is being done to under...
... Journal of the National Cancer Institute, childho...premature menopause//. Ovarian irradiation and ce...ost common risk factors associated with early meno...hildren or adolescents diagnosed with cancer will ...
...MA) has issued a warning that the nation could be ... future due to a lack of clinical expertise. Dr M...the federal MPs and senators insisting for a strat... deal with the increase in number of students. He ...
...that inhabitants of Phet where hundreds of poultry...since they had a feast on these birds. Public hea...ichit are trying to create awareness of bird flu a...usly here. Dr. Prachak Wattanakun, a provincial he...
Other Medicine News:
(Date:8/27/2008)...s of Bucks, Delaware, Montgomery,Philadelphia Cou...swire/ -- After encouraging,results following the ...f,Environmental Protection will continue its effor...mosquito-borne West Nile virus., Targeted aerial ...,midnight in portions of Bucks, Delaware, Montgome...
(Date:8/27/2008)...art Center at The Children,s Hospital at, Montef...ge of Care and Specialty...Team Treats Every Heart Condition, NEW YORK, Aug....ital at,Montefiore (CHAM) is bringing the medical ...Bronx, following the recent approval of its,transp...
(Date:8/26/2008)...re/ -- Semafore Pharmaceuticals Inc.,presented dat...d Therapies,in Cancer in Washington, D.C., announc...nhibitors that demonstrate significant anticancer,...prietary molecular scaffold has been developed usi...of pan-PI3 kinase inhibitors,as well as isoform-se...
(Date:8/26/2008)...ative Manufacturing - Has Potential to ...OCKVILLE, Md., Aug. 26 /- N...rable results from the second stage of,the Phase I...a virus-like,particle (VLP) vaccine candidate. The...ced robust neutralizing antibody responses. Novava...
Breaking Medicine Technology:DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 2DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 3Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 2Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 3Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 4Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 2Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 3Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 4Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 5Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 6GPC Biotech Today Announced Results of Survival Analysis from the SPARC Trial 5049 1GPC Biotech Today Announced Results of Survival Analysis from the SPARC Trial 5049 2GPC Biotech Today Announced Results of Survival Analysis from the SPARC Trial 5049 3Obama Pledges Major Expansion of AIDS and Global Poverty Programs 5048 1Obama Pledges Major Expansion of AIDS and Global Poverty Programs 5048 2Demand for Spanish Language Cancer Web Materials Quadruples 3B Internet Resources and Access Remain Scarce 704 1Demand for Spanish Language Cancer Web Materials Quadruples 3B Internet Resources and Access Remain Scarce 704 2Hospital to Hold MRSA Briefing for Media and Community Leaders 702 1Hospital to Hold MRSA Briefing for Media and Community Leaders 702 2
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
Medicine Products: